UPDATE: Barclays Downgrades Vertex (VRTX) to Equalweight
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
(Updated - November 29, 2016 8:16 AM EST)
Barclays downgraded Vertex (NASDAQ: VRTX) from Overweight to Equalweight with a price target of $90.00 (from $100.00). Analysts don’t see a lot of opportunity for Kalydeco/Orkambi/EPS upside in 2017.
Shares of Vertex closed at $86.90 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Downgrades DAVIDsTEA (DTEA) to Market Perform
- Jefferies Raises Price Target on Finisar (FNSR) to $37 Following 2Q Beat and Raise
- JPMorgan Downgrades Alliance Data Systems (ADS) to Neutral
Create E-mail Alert Related CategoriesAnalyst PT Change, Downgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!